Meanwhile, the S&P BSE Sensex was down 138.64 points, or 0.45% at 31,999.57. The S&P BSE Small-Cap index was down 172.79 points, or 1.12% at 15,209.11.

On the BSE, 98,000 shares were traded on the counter so far as against the average daily volumes of 44,406 shares in the past one quarter. The stock had hit a high of Rs 153.90 so far during the day, which is also its 52-week high. The stock hit a low of Rs 140 so far during the day. The stock had hit a 52-week low of Rs 67.65 on 24 June 2016.

The stock had outperformed the market over the past one month till 23 June 2017, advancing 15.57% compared with the Sensex's 2.55% rise. The scrip had also outperformed the market over the past one quarter advancing 24.75% as against the Sensex's 6.16% rise. The scrip had also outperformed the market over the past one year advancing 88.68% as against the Sensex's 15.32% rise.

The small-cap company has equity capital of Rs 4.42 crore. Face value per share is Rs 2.

Shares of Vimta Labs jumped 20.38% in eight trading sessions to its current market price of Rs 142.05, from a close of Rs 118 on 14 June 2017.

Vimta Labs' net profit rose 32.6% to Rs 2.40 crore on 19.9% increase in net sales to Rs 39.47 crore in Q4 March 2017 over Q4 March 2016.

Vimta Labs is engaged in the business of contract research and testing services. The company provides services of testing and contract research in the fields of clinical and pre-clinical studies, clinical reference, analytical testing, advanced molecular biology and environmental studies.